On the public citation graph

Inhibition of cyclic adenosine-3',5'-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogs

0 signed · 75 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4530852openalex-extracted
New Synthesis of Β-Aryl-Gaba Drugs
inferred← citeshttps://doi.org/10.1002/9780470125786.ch7openalex-snapshot
Molecular Surfaces
inferred← citeshttps://doi.org/10.1002/9783527630035.ch3openalex-snapshot
Application of Molecular Modeling in Analogue‐Based Drug Discovery
inferred← citeshttps://doi.org/10.1002/ardp.19963290406openalex-snapshot
Inhibition of Type 4 Cyclic Nucleotide Phosphodiesterase by 8‐Chloroxanthines
inferred← citeshttps://doi.org/10.1002/bkcs.11995openalex-snapshot
Structure Activity Relationship of 4‐Phenyl‐1‐(1‐Acylindolin‐5‐Ylsulfonyl)Pyrrolidin‐2‐Ones on Anticancer Activity
inferred← citeshttps://doi.org/10.1002/ejoc.201301659openalex-snapshot
Synthesis of α‐Amino‐γ‐lactams through Pd‐Catalzed Intramolecular Allylic Alkylation of Sarcosine Allyl Amides
inferred← citeshttps://doi.org/10.1002/jcb.25798openalex-snapshot
Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival
inferred← citeshttps://doi.org/10.1002/jhet.2380openalex-snapshot
Ferrocenyl, Alkyl, and Aryl‐Pyrido[2,3‐d]Pyrimidines as Vasorelaxant of Smooth Muscle of Rat Aorta via cAMP Conservation Through Phosphodiesterase Inhibition
inferred← citeshttps://doi.org/10.1002/mnfr.201100307openalex-snapshot
Anti‐proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1
inferred← citeshttps://doi.org/10.1002/qsar.19970160307openalex-snapshot
A Pharmacophore Model for PDE IV Inhibitors
inferred← citeshttps://doi.org/10.1007/978-94-011-3262-6_5openalex-snapshot
Non-Visual Molecular Shape Analysis: Shape Changes in Electronic Excitations and Chemical Reactions
inferred← citeshttps://doi.org/10.1007/bf00918994openalex-snapshot
Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response
inferred← citeshttps://doi.org/10.1007/bf02976547openalex-snapshot
Synthesis and biological studies of catechol ether type derivatives as potential phosphodiesterase (PDE) IV inhibitors
inferred← citeshttps://doi.org/10.1016/0960-894x(95)00336-ropenalex-snapshot
Phosphodiesterase type IV (PDE IV) inhibition. Synthesis and evaluation of a series of 1,3,4-trisubstituted pyrrolidines
inferred← citeshttps://doi.org/10.1016/b978-0-12-374194-3.00020-2openalex-snapshot
Substituent Groups
inferred← citeshttps://doi.org/10.1016/b978-0-12-417205-0.00013-4openalex-snapshot
Substituent Groups
inferred← citeshttps://doi.org/10.1016/b978-012210720-7/50014-9openalex-snapshot
Characterization of Different States of PDE4 by Rolipram and RP 73401
inferred← citeshttps://doi.org/10.1016/b978-012210720-7/50015-0openalex-snapshot
Molecular Aspects of Inhibitor Interaction with PDE4
inferred← citeshttps://doi.org/10.1016/b978-012744481-9/50023-4openalex-snapshot
SPECIFIC SUBSTITUENT GROUPS
inferred← citeshttps://doi.org/10.1016/j.bmc.2017.08.045openalex-snapshot
Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2006.11.019openalex-snapshot
Potent and selective xanthine-based inhibitors of phosphodiesterase 5
inferred← citeshttps://doi.org/10.1016/j.bmcl.2008.01.117openalex-snapshot
Rhodanine derivatives as novel inhibitors of PDE4
inferred← citeshttps://doi.org/10.1016/j.cellsig.2010.08.015openalex-snapshot
Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis
inferred← citeshttps://doi.org/10.1016/j.ejmech.2003.09.001openalex-snapshot
3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.01.049openalex-snapshot
Phenylpyridine-2-ylguanidines and rigid mimetics as novel inhibitors of TNFα overproduction: Beneficial action in models of neuropathic pain and of acute lung inflammation
inferred← citeshttps://doi.org/10.1016/j.farmac.2003.08.005openalex-snapshot
Synthesis and biological evaluation of neutrophilic inflammation inhibitors
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2005.07.003openalex-snapshot
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
inferred← citeshttps://doi.org/10.1016/j.tet.2020.131821openalex-snapshot
Asymmetric synthesis of piperidines using the nitro-Mannich reaction☆
inferred← citeshttps://doi.org/10.1016/j.tet.2023.133648openalex-snapshot
New synthesis of β-aryl-GABA drugs
inferred← citeshttps://doi.org/10.1016/j.tetasy.2013.02.016openalex-snapshot
Studies on the chemoenzymatic synthesis of 3-phenyl-GABA and 4-phenyl-pyrrolid-2-one: the influence of donor of the alkoxy group on enantioselective esterification
inferred← citeshttps://doi.org/10.1016/s0014-5793(02)03396-3openalex-snapshot
Crystal structure of phosphodiesterase 4D and inhibitor complex1
inferred← citeshttps://doi.org/10.1016/s0065-7743(08)60732-0openalex-snapshot
Chapter 19. Isozyme-Selective Phosphodiesterase Inhibitors as Antiasthmatic Agents
inferred← citeshttps://doi.org/10.1016/s0065-7743(08)61190-2openalex-snapshot
Chapter 3. Progress in Antidepressant Drugs
inferred← citeshttps://doi.org/10.1016/s0079-6468(08)70302-3openalex-snapshot
1 Phosphodiesterase Type IV Inhibitors
inferred← citeshttps://doi.org/10.1016/s0960-894x(00)00449-2openalex-snapshot
The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I
inferred← citeshttps://doi.org/10.1016/s0960-894x(00)80054-2openalex-snapshot
The selective inhibition of phosphodiesterase IV by benzopyran derivatives of rolipram
inferred← citeshttps://doi.org/10.1016/s0960-894x(01)00668-0openalex-snapshot
Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor
inferred← citeshttps://doi.org/10.1016/s0960-894x(01)00817-4openalex-snapshot
Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors
inferred← citeshttps://doi.org/10.1016/s0960-894x(01)80384-xopenalex-snapshot
Structure-activity relationships involving the catechol subunit of rolipram
inferred← citeshttps://doi.org/10.1016/s0960-894x(03)00405-0openalex-snapshot
Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-Asthmatics
inferred← citeshttps://doi.org/10.1016/s0960-894x(03)00493-1openalex-snapshot
Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors
inferred← citeshttps://doi.org/10.1016/s0960-894x(97)10206-2openalex-snapshot
Quaternary substituted PDE4 inhibitors I: The synthesis and in vitro evaluation of a novel series of oxindoles
inferred← citeshttps://doi.org/10.1016/s0960-894x(98)00036-5openalex-snapshot
Quaternary substituted PDE IV inhibitors II: The synthesis and in vitro evaluation of a novel series of γ-lactams
inferred← citeshttps://doi.org/10.1016/s0960-894x(98)00324-2openalex-snapshot
The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I
inferred← citeshttps://doi.org/10.1016/s0960-894x(98)00572-1openalex-snapshot
Orally active indole N-oxide PDE4 inhibitors
inferred← citeshttps://doi.org/10.1016/s0969-8051(01)00206-2openalex-snapshot
Characterization of R-[11C]rolipram for PET imaging of phosphodiesterase-4: in vivo binding, metabolism, and dosimetry studies in rats
inferred← citeshttps://doi.org/10.1021/jm010838copenalex-snapshot
Novel Selective PDE4 Inhibitors. 2. Synthesis and Structure−Activity Relationships of 4-Aryl-Substituted cis-Tetra- and cis-Hexahydrophthalazinones
inferred← citeshttps://doi.org/10.1021/jm0110338openalex-snapshot
Novel Selective Phosphodiesterase (PDE4) Inhibitors. 4. Resolution, Absolute Configuration, and PDE4 Inhibitory Activity of cis-Tetra- and cis-Hexahydrophthalazinones
inferred← citeshttps://doi.org/10.1021/jm0110340openalex-snapshot
Novel Selective PDE4 Inhibitors. 3. In Vivo Antiinflammatory Activity of a New Series of N-Substituted cis-Tetra- and cis-Hexahydrophthalazinones
inferred← citeshttps://doi.org/10.1021/jm040217uopenalex-snapshot
The Next Generation of Phosphodiesterase Inhibitors: Structural Clues to Ligand and Substrate Selectivity of Phosphodiesterases
inferred← citeshttps://doi.org/10.1021/jm049289bopenalex-snapshot
Searching for a Reliable Orientation of Ligands in Their Binding Site: Comparison between a Structure-Based (Glide) and a Ligand-Based (FIGO) Approach in the Case Study of PDE4 Inhibitors
inferred← citeshttps://doi.org/10.1021/jm701635jopenalex-snapshot
Design, Synthesis, and Structure−Activity Relationship, Molecular Modeling, and NMR Studies of a Series of Phenyl Alkyl Ketones as Highly Potent and Selective Phosphodiesterase-4 Inhibitors
inferred← citeshttps://doi.org/10.1021/jm800582jopenalex-snapshot
Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1021/jm970090ropenalex-snapshot
1,4-Cyclohexanecarboxylates: Potent and Selective Inhibitors of Phosophodiesterase 4 for the Treatment of Asthma
inferred← citeshttps://doi.org/10.1021/jm980314lopenalex-snapshot
Novel, Potent, and Selective Phosphodiesterase-4 Inhibitors as Antiasthmatic Agents: Synthesis and Biological Activities of a Series of 1-Pyridylnaphthalene Derivatives
inferred← citeshttps://doi.org/10.1021/jo0484880openalex-snapshot
Synthesis of 4-Aryl-2-pyrrolidones and β-Aryl-γ-amino-butyric Acid (GABA) Analogues by Heck Arylation of 3-Pyrrolines with Arenediazonium Tetrafluoroborates. Synthesis of (±)-Rolipram on a Multigram Scale and Chromatographic Resolution by Semipreparative Chiral Simulated Moving Bed Chromatography
inferred← citeshttps://doi.org/10.1111/j.1476-5381.2011.01729.xopenalex-snapshot
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
inferred← citeshttps://doi.org/10.1160/th14-05-0454openalex-snapshot
Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition
inferred← citeshttps://doi.org/10.1172/jci116922openalex-snapshot
Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model.
inferred← citeshttps://doi.org/10.1201/9781420020847-33openalex-snapshot
Medicinal Chemistry of PDE4 Inhibitors
inferred← citeshttps://doi.org/10.1201/9781420020847.ch33openalex-snapshot
Medicinal Chemistry of PDE4 Inhibitors
inferred← citeshttps://doi.org/10.1248/cpb.49.1009openalex-snapshot
Synthesis and Structure-Activity Relationship of N-Arylrolipram Derivatives as Inhibitors of PDE4 Isozymes.
inferred← citeshttps://doi.org/10.1254/jjp.76.193openalex-snapshot
Role of Phosphodiesterase 4 Isoenzyme in Alkaline Phosphatase Activation by Calcitonin in Porcine Kidney LLC-PK1 Cells
inferred← citeshttps://doi.org/10.1254/jjp.79.477openalex-snapshot
Effects of XT-44, a Phosphodiesterase 4 Inhibitor, in Osteoblastgenesis and Osteoclastgenesis in Culture and Its Therapeutic Effects in Rat Osteopenia Models
inferred← citeshttps://doi.org/10.1371/journal.pone.0028899openalex-snapshot
Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor
inferred← citeshttps://doi.org/10.1517/13543776.3.1.56openalex-snapshot
Patent Evaluation: Pyrrolidinone PDE inhibitors
inferred← citeshttps://doi.org/10.1517/13543776.8.5.531openalex-snapshot
TNF-α inhibitors and rheumatoid arthritis
inferred← citeshttps://doi.org/10.1517/13543776.8.7.899openalex-snapshot
Benzofuran and quinoline carboxamides and quinoline sulfonamides as TNF inhibitors and as PDE4 inhibitors
inferred← citeshttps://doi.org/10.1517/13543784.10.7.1361openalex-snapshot
Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.3390/cells8121511openalex-snapshot
Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/ijms231810616openalex-snapshot
The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
inferred← citeshttps://doi.org/10.3390/m2130openalex-snapshot
(2RS,3aRS,9aRS)-3a-Methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one Hydrobromide
inferred← citeshttps://doi.org/10.3390/molecules201219830openalex-snapshot
Efficient Synthesis of β-Aryl-γ-lactams and Their Resolution with (S)-Naproxen: Preparation of (R)- and (S)-Baclofen
inferred← citeshttps://doi.org/10.3390/molecules25040899openalex-snapshot
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets
inferred← citeshttps://doi.org/10.5935/1984-6835.20150034openalex-snapshot
Structural Optimization of 6-aryl Pyridazin3-ones as Novel Potent PDE4 Inhibitors
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.